Free Trial
→ Jeff Brown's Urgent March 17th Alert (From Brownstone Research) (Ad) Free DNTH Stock Alerts

Dianthus Therapeutics (DNTH) SEC Filings & 10K Form

Dianthus Therapeutics logo
$19.74 -1.86 (-8.59%)
As of 03:21 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Compare

Recent Dianthus Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
02/14/2025
5:32 PM		Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SCHEDULE 13G/A
02/14/2025
6:54 AM		BCLS Fund III Investments, LP (Filed by)
Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
Form SCHEDULE 13G/A
02/05/2025
4:42 PM		Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
Octagon Capital Advisors LP (Filed by)
Form SCHEDULE 13G/A
02/04/2025
3:21 PM		Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Randhawa Simrat (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
3:23 PM		Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Veness Adam M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
3:27 PM		CARR EDWARD (Reporting)
Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
8:19 PM		Avidity Partners Management LP (Filed by)
Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
Form SC 13D/A
11/22/2024
3:41 PM		Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
TCG Crossover GP II, LLC (Filed by)
Form SC 13G
11/14/2024
4:47 PM		Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Form SC 13G/A
11/14/2024
4:48 PM		5AM Partners VII, LLC (Filed by)
Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
Form SC 13G/A
10/24/2024
1:02 PM		BlackRock, Inc. (Filed by)
Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
Form SC 13G
10/21/2024
3:19 PM		Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
Form RW
10/09/2024
11:15 PM		Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
Form EFFECT
10/09/2024
11:15 PM		Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
Form EFFECT
10/01/2024
7:00 PM		Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Fairmount Funds Management LLC (Reporting)
Kiselak Tomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
3:31 PM		Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
10/01/2024
3:36 PM		Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
09/18/2024
4:38 PM		Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Romano Steven J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2024
4:32 PM		Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Romano Steven J. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2024
7:45 PM		Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
Viridian, LLC (Filed by)
Form SC 13D/A
08/08/2024
3:26 PM		Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/06/2024
7:00 AM		Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/28/2024
6:57 PM		Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Fairmount Funds Management LLC (Reporting)
Kiselak Tomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
6:58 PM		Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Lawton Alison Frances (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
6:58 PM		Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
McGeorge Anne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
6:58 PM		Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
MOULDER LEON O JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
6:59 PM		Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Soteropoulos Paula (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
7:02 PM		Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Violin Jonathan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
7:03 PM		Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Garcia Marino (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
7:04 PM		Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Savitz Ryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
7:04 PM		Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Randhawa Simrat (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
7:05 PM		Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Veness Adam M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
7:05 PM		CARR EDWARD (Reporting)
Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
4:24 PM		Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
Form 424B3
05/28/2024
4:20 PM		Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
3:20 PM		Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2024
3:08 PM		Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/11/2024
3:05 PM		Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
Form DEF 14A
04/11/2024
3:09 PM		Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
Form DEFA14A
04/11/2024
3:10 PM		Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
Form ARS
04/01/2024
5:34 PM		Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
Fairmount Funds Management LLC (Filed by)
Form SC 13D/A
Jeff Brown's Urgent March 17th Alert (Ad)

Elon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.

I urge you to watch this video now.
04/01/2024
5:21 PM		Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Fairmount Funds Management LLC (Reporting)
Kiselak Tomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
11:15 PM		Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
Form EFFECT
03/21/2024
4:02 PM		Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
Form S-1/A
03/21/2024
4:10 PM		Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:DNTH) was last updated on 3/3/2025 by MarketBeat.com Staff
From Our Partners
DOGE Social Security bombshell?
Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...
Altimetry | Sponsored
Elon Musk Wants to Audit Fort Knox—What It Means for Your Retirement
You can take advantage of the coming tariff-fueled gold melt-up right inside your IRA or 401(k) – 100% TAX-FRE...
Colonial Metals | Sponsored
This Crypto Is Set to Explode in February
It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...
Crypto 101 Media | Sponsored
The Deep State Surveillance Plot To Sabotage President Trump
There's a Trump approved IRS-loophole which allows you to steer clear of government overreach and move your re...
American Hartford Gold | Sponsored
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...
Crypto Swap Profits | Sponsored
Urgent update to my gold outlook
Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...
Golden Portfolio | Sponsored
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored
3 Undervalued Stocks to Get Today (Revealed)
These 3 Stocks Should Do Well Even in a Recession If you’re looking for stocks that offer significant upsid...
StockEarnings | Sponsored